Report Description

United Kingdom Stent Market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The rising incidences of cardiovascular disorders across the United Kingdom are primarily driving the growth of the market. In addition to this, the proliferating cases of several ailments such as ischemic heart disease, peripheral artery disease (PAD), and aortic aneurysm is also adding to the market growth. Moreover, the growing geriatric population across the UK, who are more prone to such ailments, is further adding to the product demand. Apart from this, the sedentary lifestyle, unhealthy eating choices, along with high consumption of alcohol, and smoking habits, are adding to the occurrences of such severe ailments, which eventually is providing a thrust to the United Kingdom stent market.

Stent refers to a small mesh tube that is primarily utilized to open and hold passages in the body, particularly in weak and narrow coronary arteries. This provides the heart with oxygen-rich blood. Stents are generally inserted in an angioplasty procedure where plaque blocks a blood vessel. They are inserted either as an emergency to treat a heart attack or in a planned manner to wide open an artery that is blocked by fatty plaque.

Rising Preferences for Minimally Invasive Procedures Fuel the Market Growth

Growing inclination towards minimally invasive surgeries (MIS) is another major factor anticipated to propel the growth of the United Kingdom stent market over the forecasted period. Minimally invasive procedures involve small incisions with minimal pain, hence leading to higher patient satisfaction. These procedures also facilitate shorter hospital stays and quick recovery. Moreover, technological advancements in stents, such as the utilization of biodegradable materials in stent manufacturing and the development of bifurcated stents, have enabled improved treatment of cardiovascular diseases. Along with this, several companies are increasingly involved in the research and development of innovative products and strategic partnerships collaborations to expand the market reach.

Rising Prevalence of Cardiovascular and Lifestyle Diseases Drives the Product Demand

The increasing aging population in the United Kingdom has resulted in the increased number of patients with cardiovascular diseases as the geriatric population is more prone to such ailments. In 2020, people aged 65+ accounted for the share of 18.65% out of 67.26 million population in United Kingdom. Moreover, the rising cases of hypertension have also resulted in increased incidences of cardiovascular diseases. In addition, the bolstering number of obese people across the United Kingdom due to sedentary and unhealthy lifestyle choices is acting as another major risk factor responsible for CVDs. Excessive fat inside the arteries leads to various health problems such as coronary heart diseases. As a result, the demand for stents is surging across all the healthcare facilities based in the UK, thereby propelling the growth of the United Kingdom stent market.